Single-injection FGF21 gene therapy treatment for obesity and insulin resistance succeeds in two different mouse models of obesity, induced either by diet or by genetic mutation, counteracting obesity and insulin resistance for 12+ months.

See the source article by following the link below:
Single-injection FGF21 gene therapy treatment for obesity and insulin resistance succeeds in two different mouse models of obesity, induced either by diet or by genetic mutation, counteracting obesity and insulin resistance for 12+ months.